POSTPONED
Register and we will notify you with the new launch date

​As today’s biotechnology companies navigate the many complexities of clinical research, they’re frequently challenged to make otherwise immature financial systems more sophisticated and supportive of pre-commercialization activities, compliance needs, and go-to-market timelines.

On top of that, many biotech companies are themselves leaner and potentially geographically dispersed, making it even harder to embrace an enterprise-wide approach without disrupting their everyday clinical workflows. The solution? Business Spend Management (BSM). In this webinar, we’ll examine how clinical-stage biotechnology company, Arvinas, partnered with Coupa and Sikich to transform its financial systems for a more integrated and streamlined process. You’ll learn: 

• What went into the transformation from a manual to electronic workflow
• How their new solution better supports their pathway to commercialization
• Why a BSM approach supports audit-readiness and tighter controls post-IPO

SPEAKERS

Jim Ingram
Senior Mid-Market Account Executive
Sikich LLP

Jeff Byrd
Regional Vice President of Life Sciences
Coupa Software

Puneet Kapoor
Director, IT Finance Systems
Arvinas